BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 70271)

  • 1. Distribution and excretion of 14C-cyclocytidine in experimental animals.
    El Dareer SM; White VM; Tillery K; Chen FP; Mellett LB; Hill DL
    Cancer Treat Rep; 1977 Aug; 61(5):805-14. PubMed ID: 70271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical model for cyclocytidine pharmacokinetics.
    Himmelstein KJ; Gross JF
    J Pharm Sci; 1977 Oct; 66(10):1441-4. PubMed ID: 72816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine.
    Kirsch LE; Notari RE
    J Pharm Sci; 1984 Jun; 73(6):728-32. PubMed ID: 6204036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
    Takenaka T; Kimura K
    Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tissue distribution and fate of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and 1-beta-D-arabinofuranosyl-5-fluorocytosine in rats.
    Chou TC; Vidal P; Phillips FS
    Cancer Treat Rep; 1977 Jul; 61(4):617-24. PubMed ID: 69496
    [No Abstract]   [Full Text] [Related]  

  • 7. Some cardiovascular effects of cyclocytidine.
    Herman EH; Chadwick DP
    Cancer Treat Rep; 1976 Nov; 60(11):1663-6. PubMed ID: 66094
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyramine-like effect of cyclocytidine (2,2'-anhydro-1-beta-arabinofuranosylcytosine hydrochloride), an antineoplastic agent.
    Oguro K; Hashimoto K
    Tohoku J Exp Med; 1978 Jan; 124(1):83-90. PubMed ID: 76345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of cyclocytidine and arabinosylcytosine disposition in rats.
    Novotný L; Farghali H; Janků I; Beránek J
    Neoplasma; 1988; 35(6):707-14. PubMed ID: 2464769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclocytidine ocusert].
    Chen ZJ
    Zhonghua Yan Ke Za Zhi; 1983 Nov; 19(6):343-5. PubMed ID: 6202470
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of hypoplastic leukemia in advanced age induced into complete remission with continuous drip infusion of cyclocytidine and prednisolone (author's transl)].
    Wakiya I; Ban S; Ishii Y; Yagiri Y; Miyake Y
    Rinsho Ketsueki; 1982 Feb; 23(2):180-4. PubMed ID: 6178859
    [No Abstract]   [Full Text] [Related]  

  • 12. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine.
    Kirsch LE; Notari RE
    J Pharm Sci; 1984 Jul; 73(7):896-902. PubMed ID: 6206222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of some biochemical parameters of arabinosylcytosine and cyclocytidine in L1210 murine leukemia cells.
    Novotný L; Reichelová V; Balázová E; Ujházy V
    Neoplasma; 1990; 37(1):13-22. PubMed ID: 1690864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution and excretion of cyclocytidine in monkeys, dogs, and rats.
    Hirayama H; Sugihara T; Hamada F; Kanai T; Hikita J
    Gan; 1974 Apr; 65(2):153-61. PubMed ID: 4209835
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of the cardiovascular actions of cyclocytidine.
    Burks TF; Loo TL; Grubb MN
    Proc Soc Exp Biol Med; 1978 Dec; 159(3):374-9. PubMed ID: 83653
    [No Abstract]   [Full Text] [Related]  

  • 18. The absorption, metabolism and excretion of disodium cromoglycate in nine animal species.
    Ashton MJ; Clark B; Jones KM; Moss GF; Neale MG; Ritchie JT
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):319-28. PubMed ID: 4203381
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
    Finklestein JZ; Higgins G; Krivit W; Hammond D
    Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of storage of anhydro-araC.
    Schrier WH; Hayashikawa RH; Nagyvary J
    Biochem Pharmacol; 1977 Dec; 26(24):2375-8. PubMed ID: 74253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.